VivoSim Labs, Inc. Payments of Financing Costs
VivoSim Labs, Inc. (VIVS) reported Payments of Financing Costs of $0 for the 12-month period ending 2016-03-31, per its 10-K filed 2016-06-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2016-06-09
- VivoSim Labs, Inc. payments of financing costs for the quarter ending 2013-03-31 was $0.00.
- VivoSim Labs, Inc. payments of financing costs for the quarter ending 2012-03-31 was $0.00, a 100.00% decline year-over-year.
- VivoSim Labs, Inc. payments of financing costs for the quarter ending 2011-12-31 was $232.02K.
- VivoSim Labs, Inc. payments of financing costs for the quarter ending 2011-09-30 was $199.57K.
- VivoSim Labs, Inc. payments of financing costs for fiscal 2016 was $0.00.
- VivoSim Labs, Inc. payments of financing costs for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- VivoSim Labs, Inc. payments of financing costs for fiscal 2014 was $40.00K.
- VivoSim Labs, Inc. payments of financing costs for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month | Payments of Financing Costs 12 month | Payments of Financing Costs 59 month | Payments of Financing Costs 62 month | Payments of Financing Costs 65 month | Payments of Financing Costs 68 month | Payments of Financing Costs 71 month | Payments of Financing Costs 74 month | Payments of Financing Costs 77 month | Payments of Financing Costs 80 month | Payments of Financing Costs 83 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-03-31 | $0.00 10-K · filed 2016-06-09 | ||||||||||||
| 2015-03-31 | $0.00 10-K · filed 2016-06-09 | ||||||||||||
| 2014-03-31 | $40.00K 10-K · filed 2016-06-09 | $478.00K 10-K · filed 2014-06-10 | |||||||||||
| 2013-12-31 | $438.00K 10-Q · filed 2014-02-06 | ||||||||||||
| 2013-09-30 | $438.00K 10-Q · filed 2013-11-08 | ||||||||||||
| 2013-06-30 | $438.00K 10-Q · filed 2013-08-09 | ||||||||||||
| 2013-03-31 | $0.00 10-K · filed 2015-06-09 | $438.00K 10-KT · filed 2013-05-24 | |||||||||||
| 2012-12-31 | $0.00 10-K · filed 2015-06-09 | $438.00K 10-K · filed 2013-03-15 | |||||||||||
| 2012-09-30 | $438.30K 10-Q · filed 2012-11-14 | ||||||||||||
| 2012-06-30 | $438.30K 10-Q · filed 2012-08-14 | ||||||||||||
| 2012-03-31 | $0.00 10-K · filed 2015-06-09 | $232.02K derived: sum of 2 quarters · filed 2015-06-09 | $431.58K derived: sum of 3 quarters · filed 2015-06-09 | $437.10K derived: sum of 4 quarters · filed 2015-06-09 | $438.30K 10-Q · filed 2012-05-15 | ||||||||
| 2011-12-31 | $232.02K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-10 | $431.58K derived: sum of 2 quarters · filed 2014-06-10 | $437.10K derived: sum of 3 quarters · filed 2014-06-10 | $438.00K 10-K · filed 2014-06-10 | |||||||||
| 2011-09-30 | $199.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $205.08K derived: sum of 2 quarters · filed 2012-11-14 | $205.98K 10-Q · filed 2012-11-14 | ||||||||||
| 2011-06-30 | $5.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $6.42K 10-Q · filed 2012-08-14 | |||||||||||
| 2011-03-31 | $901.00 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |